Mutation specific biosensors to accelerate drug development

KinCon biolabs is a biotech startup based in Innsbruck Austria. We develop a constantly expanding platform of unique live-cell activity biosensors.

Our Mission

Precision medicine
Reviving enzymes
KinCon biolabs advances the identification of the most efficient, mutation-specific drug candidates to accelerate drug development.
We are setting out to reactivate compartmentalized and mutated enzyme pathways to identify first in class treatments for neurodegenerative disorders.

Technology

Profiling Kinase Conformations

Technology

patient mutations
drug selectivity
drug efficacy
> 500 kinases
Kinases are central molecular switches. Mutations in kinase encoding genes contribute to the etiology and progression of cancer and other diseases. There is a constant need for novel effective  kinase-specific drugs.
The KinCon biosensor platform allows the tracking of drug-induced changes of the protein conformation under physiological relevant conditions.
  • Protein activity measurements in living cells

    Full-length biosensors for the protein of interest are expressed in the target cell-line of choice.
  • Simple integration of patient mutations for precision medicine

    Any mutation of interest can be integrated into the respective biosensor to determine mutation specific drug (candidate) efficacies and specificities.
  • Systematic analysis

    Our technology allows dose- and time-dependent drug profiling in a high content format.

Behind the scenes

Meet the KinCon biolabs Team
Eduard Stefan
Eduard Stefan
CEO | Co-Founder
Edi is the inventor of the KinCon technology, holds a PhD in genetics and brings more than 15 years of experience in studying the functions of various kinases. He is a group-leader in the institute of molecular biology at the University of Innsbruck.
Philipp Tschaikner
Philipp Tschaikner
CSO | Co-Founder
Philipp holds a PhD in molecular cell-biology. He is responsible for steering the development of the biosensor platform and implementing our customer-projects.
Andreas Feichtner
Andreas Feichtner
Scientist
Andreas, who significantly contributed to the development and application of KinCon technology during his PhD, is now joining KinCon biolabs as a scientist. His expertise and experience will be instrumental in advancing our research and development efforts.
Gabi Reiter
Gabi Reiter
Administration
Gabi plays a vital role at KinCon bio, providing essential administrative support to ensure smooth operations. She brings a high level of organization and dedication to all her tasks, benefiting the entire team.
Alexandra Fritz
Alexandra Fritz
Industrial PhD
Alex is a foundational member of KinCon biolabs. She originally joined us as a lab technician, playing a crucial role in developing protocols and processes. Now, she is advancing our R&D efforts as an industrial PhD student, working on her own project.
Ilona Kopp
Ilona Kopp
Technician
Ilona, who joined us in March 2024, is an MD student with a BSc in Molecular Medicine, providing essential support as a lab technician at KinCon biolabs.
Christian Hörtnagl
Christian Hörtnagl
Technician
Since joining in February 2024, Christian, who holds a BSc in Chemistry, has been instrumental in advancing our lab's research capabilities with his technical proficiency.
Lorenz Klausner
Lorenz Klausner
Technician
Lorenz holds a BSc in Chemistry and contributes his expertise to support our innovative research and development projects at KinCon biolabs.

Are you interested in our biosensors or just want to connect with us?

Just fill out the form below.

Send now
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

News & Publications

See all
August 2023

KinCon biolabs Graduates from Creative Destruction Lab (CDL) Program and Joins CDL Supersession in Toronto

August 2023

KinCon biolabs GmbH Receives Health Hub Tirol Funding

June 2023

Tracking and blocking interdependencies of cellular BRAF-MEK oncokinase activities

KinCon biolabs GmbH is a University of Innsbruck spin-off company supported by funding from the Austrian Research Promotion Agency (FFG) Spin-off Fellowship, Austria Wirtschaftsservice (AWS) Preseed program , and from the State of Tyrol through the Health Hub Tirol funding program.


Swipe for more
Standortagentur Tirol
Universität Innsbruck
FFG
Austria Wirtschaftsservice GmbH